新西兰 - 英文 - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - levetiracetam 100 mg/ml - solution for infusion - 100 mg/ml - active: levetiracetam 100 mg/ml excipient: glacial acetic acid sodium acetate trihydrate sodium chloride water for injection - use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 1000mg;   - film coated tablet - 1000 mg - active: levetiracetam 1000mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry white amb 84f58775 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 250mg;   - film coated tablet - 250 mg - active: levetiracetam 250mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry blue amb 84f80803 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 500mg;   - film coated tablet - 500 mg - active: levetiracetam 500mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry yellow amb 84f82508 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 750mg;   - film coated tablet - 750 mg - active: levetiracetam 750mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry pink amb 84f84674 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

ucb australia pty ltd t/a ucb pharma division of ucb australia - levetiracetam, quantity: 750 mg - tablet, film coated - excipient ingredients: macrogol 6000; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - keppra (film coated tablets and oral solution) is indicated for - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation, - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. - add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme), and - add on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige). keppra concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.

加拿大 - 英文 - Health Canada

teva canada limited - levetiracetam - tablet - 250mg - levetiracetam 250mg - miscellaneous anticonvulsants

加拿大 - 英文 - Health Canada

teva canada limited - levetiracetam - tablet - 500mg - levetiracetam 500mg - miscellaneous anticonvulsants

加拿大 - 英文 - Health Canada

teva canada limited - levetiracetam - tablet - 750mg - levetiracetam 750mg - miscellaneous anticonvulsants

加拿大 - 英文 - Health Canada

apotex inc - levetiracetam - tablet - 250mg - levetiracetam 250mg - miscellaneous anticonvulsants